NCT06168552View on ClinicalTrials.gov

Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 15, 2023

Primary Completion Date

June 15, 2024

Study Completion Date

December 15, 2024

Conditions
Resectable Pancreatic Adenocarcinoma
Interventions
DIAGNOSTIC_TEST

Injection of fluorescent developer (anti-EGFR-IR800CW)

The patient underwent Da Vinci robot or fluorescent laparoscopy-assisted radical resection of pancreatic cancer, and anti-EGFR antibody-IR800CW imaging agent was injected in the day before surgery, and fluorescence detection was performed

All Listed Sponsors
lead

Zhejiang University

OTHER

NCT06168552 - Fluorescent Navigation Technology in Radical Resection of Pancreatic Cancer | Biotech Hunter | Biotech Hunter